Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Acquired nystagmus causes excessive motion of images on the retina, which often reduces visual acuity and produces oscillopsia (illusory motion of the seen world). The pathogenesis of several forms of acquired nystagmus is now better understood and can be related to abnormalities of mechanisms that normally hold gaze steady. Basic research on the pharmacology of the neural pathways responsible for gaze holding has demonstrated an important role for gamma aminobutyric acid and led to new drug treatments for acquired nystagmus and its visual consequences.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00055735-199612000-00007 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!